Effect of Yiqi Fumai injection improves exercise tolerance in patients with chronic heart failure: A prospective, open-label, randomized, controlled clinical trial.

Key Points

• The research aims to evaluate the impact of Yiqi Fumai injection on exercise tolerance and quality of life in chronic heart failure patients.
• Prospective, open-label, randomized controlled trial design
• Involvement of patients diagnosed with chronic heart failure
• Comparison of exercise performance before and after intervention
• Yiqi Fumai injection significantly enhances exercise tolerance
• Improves overall quality of life for patients
• Demonstrates a positive effect on cardiac function with good safety profiles